BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

WuXi AppTec Issues Positive Profit Alert with Over 100% Surge in H1 2025 Net Profit

WuXi AppTec Co., Ltd., a leading global pharmaceutical and life sciences technology platform company offering integrated, end-to-end new drug R&D and m...

July 11, 2025 | News

BioMed X and Servier Launch Europe’s First XSeed Labs at Paris-Saclay to Accelerate AI-Driven Bispecific Antibody Design

BioMed X, an independent biomedical research institute based in Heidelberg, Germany, announced the launch of a new initiative with Se...

July 10, 2025 | News

Unlocking Solubility as Lubrizol's Excipients Power the Next Generation of Drug Delivery

With up to 90% of new chemical entities suffering from poor water solubility, pharmaceutical innovators are under pressure to reformulate for eff...

July 09, 2025 | Interview

WuXi AppTec Completes RMB1 Billion A-Share Buyback and HKD2.5 Billion H-Share Acquisition to Drive Shareholder and Talent Value

WuXi AppTec Co., Ltd, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and ...

July 09, 2025 | News

Quanterix Completes Acquisition of Akoya Biosciences, Expanding Leadership in Multi-Tissue Biomarker Detection

Quanterix Corporation, a company fueling scientific discovery through ultra-sensitive biomarker detection, announced that it has completed its previously a...

July 09, 2025 | News

InnoCare Pharma Receives IND Approval in China for Novel B7-H3 Targeted ADC ICP-B794

InnoCare Pharma, a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced the approval of the Inves...

July 07, 2025 | News

Akeso Doses First Patient in Phase Ia Trial of AK146D1, the World’s First Bispecific ADC Targeting Trop2 and Nectin4

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") has announced the successful enrollment of the first patient in its Phase Ia clinical trial for AK146D1, a...

July 04, 2025 | News

Takara Bio Europe Partners with MACHEREY-NAGEL to Distribute Bioanalysis Portfolio Across Europe

Takara Bio Europe is pleased to announce it has entered into a distribution agreement with MACHEREY-NAGEL (MN), a leading global provider of analytical and...

July 02, 2025 | News

AvenCell Secures Up to $40 Million AMED Grant to Advance Dual-Antigen Allogeneic CAR-T Therapy

AvenCell Japan, a wholly owned subsidiary of AvenCell Therapeutics, a private, clinical-stage biotechnology company developing best-in-class CAR-T therapie...

July 02, 2025 | News

WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub

WuXi XDC Cayman Inc, a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, announced...

July 02, 2025 | News

Alpha Fusion and Curadh Forge Joint Venture to Advance Astatine-211 Radiopharmaceuticals Globally

Alpha Fusion, Inc. ("Alpha Fusion") and Curadh MTR Inc. ("Curadh") announced plans to enter a strategic partnership, including a Joint Venture t...

July 01, 2025 | News

XtalPi Expands AI-Driven Drug Discovery Collaboration with Pfizer to Develop Next-Generation Molecular Modeling Platform

XtalPi (2228.HK), a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking m...

June 30, 2025 | News

Invetech and AiCella Forge Strategic Alliance to Advance AI-Driven Cell Therapy Manufacturing

Invetech, a global leader in solving complex manufacturing and product development challenges in the advanced therapies and diagnostics markets, today anno...

June 27, 2025 | News

Xcell Biosciences and Thermo Fisher Scientific Unite to Advance Treg and TIL Cell Therapies for Autoimmune and Solid Tumor Diseases

Xcell Biosciences (Xcellbio), a San Francisco-based instrumentation company focused on cell and gene therapy applications, today announced a strategic coll...

June 25, 2025 | News

Stay Connected